© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Pharmaceutical history tracks the rise of Dextromethorphan Hydrobromide Monohydrate back to the mid-20th century, a time when public health priorities pivoted sharply toward safer cough remedy alternatives. Early on, opiate-based treatments like codeine posed acceptable risks for cough control, but broader use highlighted dependency issues. This led to a demand for antitussives without addictive side effects. Researchers at a major U.S. research foundation established dextromethorphan as an effective, non-narcotic cough suppressant in 1954. Approval followed swiftly, and its popularity exploded during the 1960s as manufacturers produced syrups and lozenges to meet consumer need. Health professionals recognized the value in its reduced sedation and limited abuse profile. Throughout my years of researching pharmaceutical trends, I’ve noticed that every shift—like this one toward safer medications—leaves a mark on both regulation and formulation science, echoing through new generations of drug development.
Dextromethorphan Hydrobromide Monohydrate appears on pharmacy shelves in a range of forms. Consumers know it best as an active ingredient in liquid cough medicines, tablets, and even rapid-dissolve strips. In the industry, it’s sought after for its reliable stability and ease of formulation, making it a staple across over-the-counter cold remedies. The drug’s active component interrupts signals in the brain that trigger the urge to cough, offering relief without the high potential for drowsiness that plagues older treatments. I’ve worked alongside pharmacists who point out that patients often gravitate toward products containing dextromethorphan because it allows them to function at work and home, even while fighting persistent coughs.
Dextromethorphan Hydrobromide Monohydrate appears as a white, crystalline powder with a faint odor and a slightly bitter taste. Its molecular formula, C18H25NO•HBr•H2O, underscores the combination of a hydrobromide salt and water of hydration, important for solubility and storage. This crystalline compound dissolves readily in water and less so in alcohol, which simplifies formulation in both aqueous and some solid dosage forms. The melting point falls between 120 and 125°C, a range well-suited for modern manufacturing environments, with stability maintained under typical storage conditions. Its chemically robust profile means it resists significant degradation, ensuring products stay effective from warehouse to medicine cabinet. Chemistry lab experience highlights the significance of reproducible purity, which this product’s crystalline structure helps deliver.
Manufacturers craft their labeling and technical specs around the United States Pharmacopeia (USP) or European Pharmacopoeia (Ph. Eur.) standards. Purity must exceed 98%, and measured moisture content falls within 3.0-4.5%. Lab analysis involves titration, loss on drying, specific rotation, and impurity profiling. I’ve seen regulatory teams agonize over fine details, from label font size to batch traceability, knowing that accuracy isn’t just a legal box but a patient safety guarantee. The mandated instructions break down possible side effects, dosage guidance by age, contraindications like MAOI use, plus batch numbers and expiration dates. Keeping these elements clear and unambiguous earns trust from patients and healthcare professionals alike.
Synthetic routes for Dextromethorphan Hydrobromide Monohydrate begin with the reaction of 3-methoxy-N-methylmorphinan with hydrobromic acid, followed by crystallization in the presence of water. Process chemists control temperature and solvent ratios tightly to avoid unwanted isomers or byproducts. Modern facilities favor closed-system reactors fitted with precision dosing pumps, yielding consistent broth from which pure crystals can be harvested. In practice, I’ve found that changing the order or speed of reagent addition tweaks both particle size and yield, making experienced operators indispensable. Once dried, the monohydrate is milled and tested before bulk packaging. Quality control at each step remains relentless.
The molecule’s morphinan backbone attracts researchers interested in structural tweaks to tune its activity. One common method involves O-demethylation, producing analogs such as levorphanol, a compound with very different properties. Acid or base catalysis leads to degradation products, which guide stability studies but also warn against improper storage. Some chemists use dextromethorphan as a starting point to explore non-cough suppressant therapies, chasing effects on the central nervous system’s NMDA receptors. I’ve watched medicinal chemistry teams debate potential psychiatric and neuroprotective applications, given the molecule’s influence outside classic antitussive pathways.
Across pharmacies and scientific literature, Dextromethorphan Hydrobromide Monohydrate takes on a variety of names—DM, DXM, or brands like Robitussin DM and Delsym. Chemical registries list it as 3-Methoxy-17-methylmorphinan hydrobromide monohydrate, and some packaging simply shortens it to dextromethorphan HBr. This alphabet soup confuses newcomers to the field, a point driven home each time a young pharmacy technician asks about product substitutions. Clear, consistent naming from supplier to label improves both behind-the-counter workflow and patient safety.
Safety surrounding dextromethorphan hinges on clear operational protocols. Standard operating procedures require gloves and masks due to dust inhalation risks, especially in bulk manufacturing areas. Storage containers need to be sealed and kept in controlled environments, protecting both the product and workforce. Industry audits stress traceability and rapid batch recall—a lesson hard-learned from the rare instance of cross-contamination or mislabeling. Toxicity at very high doses, including dissociative effects, pushes both manufacturers and pharmacists to reinforce education efforts about proper use, keeping community safety at the forefront. I recall consulting on a regulatory compliance project where persistent training, not just documentation, made the most impact on accident reduction.
Dextromethorphan Hydrobromide Monohydrate holds its ground as the preferred over-the-counter treatment for non-productive cough in patients over the age of four. Drug developers also investigate it for off-label uses—possible neuroprotection in neurodegenerative disease, or tools in psychiatric therapy due to its NMDA receptor antagonism. Despite widespread availability, responsible stewardship remains key. Emergency medicine practitioners recount cases of recreational misuse, tying back to online challenges and lax access controls. In my research interviews, clinicians push for stricter point-of-sale rules without clamping down on legitimate use. Some behavioral health experts see the molecule’s dual identity—as remedy and risk—as a microcosm of the wider need for balanced regulation in modern medicine.
Research teams devote significant resources to uncovering new applications for dextromethorphan. Combinations with bupropion have reached prescription status, opening paths for treatment-resistant depression. Laboratory models show promise for slowing progression in conditions like amyotrophic lateral sclerosis (ALS). Preformulation scientists fine-tune particle size and excipient compatibility to push performance in novel dosage forms—thin films, prodrugs, even sustained-release patches. In university settings, young investigators thrill at the prospect of old drugs finding new life, marrying chemical tradition with data-driven pharmacology. These research efforts—often overlooked by outsiders—drive forward clinical possibilities, especially as patient-centered care takes priority in hospital systems worldwide.
Toxicological studies reveal that therapeutic doses rarely cause harm in most populations. Still, doses much above recommended amounts bring out hallucinogenic, dissociative, and potentially cardiotoxic effects, especially in minors or people with pre-existing conditions. Chronic abuse produces cognitive effects that mimic those seen in more notorious substances. Poison centers see peaks in calls during cold and flu season, usually linked to teenage misuse. Educating both parents and younger consumers on product dangers turns out to carry more weight than warning stickers. Evidence-based policy, supported by targeted community outreach, reduces accidental poisonings and keeps the focus on safety without singling out people seeking relief from legitimate cough.
The future of Dextromethorphan Hydrobromide Monohydrate stretches beyond cough syrup. Biotech startups and pharmaceutical giants alike invest in analogs that improve central nervous system selectivity, sidestepping recreational side effects while sharpening therapeutic value. Regulatory bodies, now armed with real-world data analytics, monitor both misuse and benefit with unprecedented granularity. From what I’ve seen in drug discovery workshops, the most compelling direction means blending patient-centered feedback with relentless scientific innovation—products judged not only on chemical merit, but also on real-world care outcomes. The broader field anticipates targeted, personalized delivery technologies that keep dextromethorphan relevant across new therapeutic landscapes long after today’s cold medicine has evolved.
Dextromethorphan hydrobromide monohydrate turns up in medicine cabinets far and wide. Most folks know it as a staple in cough syrups and cold remedies. The science behind it is simple: this compound helps quiet the reflex that triggers cough inside the brain’s medulla. It doesn’t dry out the mucus or act as a painkiller, but it steps in to dial back the urge to cough, especially those hacking coughs that keep you up at night. Not many medicines get such universal trust for knocking back the disruption of a bad cold.
As someone who's raised kids and dealt with every seasonal bug out there, I notice how much parents and patients lean on over-the-counter syrups with dextromethorphan during cold season. It’s in the arsenal, not just for home use, but in clinics too. The relief doesn’t come from silencing symptoms alone — it offers peace in the day-to-day chaos of runny noses and barking coughs.
You don’t find many cough remedies on the shelf with the same track record for safety, but dextromethorphan isn’t without concerns. Younger children, especially those under four, face serious risks from accidental overdose—think slow breathing, confusion, even dangerous heart rhythms. Many health organizations warn parents about giving young kids cough medicines. Guidance from the U.S. FDA and the American Academy of Pediatrics adds weight: skip it for toddlers and stick to non-drug strategies like honey (for kids over one year) or humidifiers.
Abuse paints a darker picture. Teens catch on to the drug’s mind-altering side effects at large doses, using it in ways the original makers never intended. Emergency rooms see an uptick in cases where too much isn’t just a little too much. Dizziness, lethargy, hallucinations — the dangers aren’t theoretical. Proactive education helps. Parents and educators need to talk openly about what sits in the medicine cabinet and stay alert for warning signs of misuse. Retailers in many places now ask for age verification when just picking up a bottle.
Pharmacists and doctors see the conversations changing. Alternatives to drug therapy for cough relief keep getting airtime. Some healthcare providers urge steam, rest, and fluids before pharmaceuticals, especially for kids. And as more research comes in, especially about long-term effects or rare side effects, prescribers will keep adjusting their advice.
Dextromethorphan hydrobromide monohydrate stands as a useful tool for handling dry, nagging cough. Still, respect for dosage guidelines and age limits matter. Talk with pharmacists or doctors if questions pop up, especially with very young children or if other chronic conditions are involved. Safe use depends on practical information and honest conversations, as much as on what comes in a bottle.
Cough season always hits me hard, and like many, I’ve stood at the pharmacy shelf, weighing options. Dextromethorphan Hydrobromide Monohydrate, found in dozens of cough syrups and lozenges, is a popular choice. It’s easy to grab and even easier to down half a bottle, hoping for relief. Still, dosage matters—a lot. For adults and children over 12, most cough medicines usually recommend 10 to 20 milligrams every four hours, with a hard cap of 120 mg in 24 hours. For younger kids, especially those between 6 and 12, the advice sits closer to 5-10 mg every four hours, not exceeding 60 mg in a day. Under six? Medical professionals tell parents to steer clear of these medicines unless a doctor instructs otherwise.
Ignoring the package directions can get risky. Dextromethorphan looks harmless, but the margin between coughing less and feeling side effects is thin. I remember an awkward conversation with my pharmacist years ago about why some teens seek high doses—at larger amounts, it triggers hallucinations and dizziness. Poison control calls involving this medicine aren’t rare. In 2022, the American Association of Poison Control Centers counted thousands of cases where either accidental or intentional overconsumption sent people straight to the ER. It’s not about one-off mistakes; regular misuse builds up bigger problems, from liver strain to abnormal heart rhythms.
Trusting the advice straight from your health provider beats scrolling forums. Dextromethorphan doesn’t mix well with some medications, like antidepressants in the SSRI class. Doctors worry about serotonin syndrome—a life-threatening cluster of symptoms that crops up when some drugs combine. The FDA has flagged this mix multiple times. For people living with chronic cough from something like asthma or who already take multiple prescriptions, a pharmacist’s advice becomes even more critical.
Child-proof caps and bold warnings on bottles exist for a reason. As a parent, it’s tempting to reach for whatever promises relief, but reading dosage instructions—checking them twice—always pays off. A cough might just need rest and fluids, and dosing outside the guidelines doesn’t speed up recovery. At home, I stick to measuring spoons or oral syringes, not kitchen teaspoons, to avoid making mistakes.
Nobody benefits from hidden risks on medication labels. Big companies now include clearer dosage charts right on the box, and schools run drug awareness programs that go beyond just “say no.” What we really need is honest talk, not scare tactics. Check resources like the FDA’s website or reach out to a healthcare professional when in doubt. Even trusted over-the-counter drugs deserve respect and attention.
The right dosage of Dextromethorphan Hydrobromide Monohydrate isn’t one-size-fits-all. Population health studies and toxicology research back the numbers on the bottles. Nobody’s immune from mix-ups, and nobody should have to guess. Double-check the directions; listen to professionals. It saves trouble and delivers actual relief, not new problems.
Dextromethorphan Hydrobromide Monohydrate often turns up in over-the-counter cough syrups. Most folks don’t give it a second thought and trust what’s on the pharmacy shelf. A regular bottle can soothe a cough, but those little sips bring more to the table than just relief.
More times than I’d like to admit, I’ve relied on cough syrup in the thick of cold season. Along the way, I noticed feeling strange—sometimes dizzy, sometimes walking around in a fog. These are not rare stories. Many people feel drowsy, lightheaded, or a bit woozy after a recommended dose. Some even get mild stomach upset or nausea. These short-lived annoyances signal your body’s response to the medicine. Kids and older folks can feel it more, especially if they take other medications or have existing medical problems.
Most headlines covering this drug focus on intentional misuse, especially among teenagers. Too much dextromethorphan can cause confusion, agitation, and unsteady movements. It sometimes triggers hallucinations or ringing in the ears, which can scare anyone who isn’t expecting it. In extreme cases, heart palpitations, high blood pressure, slowed breathing, or even seizures can set in. People with a history of mood disorders may face a bigger risk for mood changes or other mental effects. This is not just scare talk; emergency rooms report a steady trickle of cases linked to cough syrup overuse.
Dextromethorphan can clash with antidepressants like SSRIs or MAOIs. This mix-up can cause serious trouble—something called serotonin syndrome. Symptoms range from sweating and fever to muscle twitches and agitation. Severe cases lead to rapid heart rates and possible collapse. I’ve seen folks completely unaware that their flu remedy could spark a dangerous reaction with their regular meds. Pharmacists try to ask about prescriptions, but the truth is, not everyone tells them the whole story.
People with asthma, liver problems, or persistent coughs often reach for fast relief. Unfortunately, dextromethorphan can worsen breathing problems or create unwanted side effects. Sometimes I feel tempted to reach for a fix when my throat hurts or I can’t sleep. Scratching that itch with a strong over-the-counter has a way of becoming a habit before you notice it.
Reading the label before sloshing syrup in a spoon makes more sense now than ever. Ask a pharmacist about safe combinations, especially if you take more than a single prescription. Parents can help teens understand the danger of using cough medicine to try to get high, since one easy purchase can spiral into something unpredictable. I keep my medicine cabinet organized and toss out expired bottles, since old meds can hit harder or act differently.
Reporting side effects to a healthcare provider tells the real-world story of how ordinary people react. It also reminds medical professionals which warnings matter most. New health information keeps surfacing, so nobody should feel embarrassed asking questions—sometimes a short conversation can steer you clear of bigger problems.
Dextromethorphan Hydrobromide Monohydrate offers quick relief, but using it means paying attention to health history, staying honest with your doctor, and treating over-the-counter remedies with the same caution as their prescription cousins.
Cough medicine often looks harmless. Most people see the bottle, read “non-drowsy,” and grab it without a second thought. Dextromethorphan hydrobromide monohydrate—the active ingredient in popular over-the-counter cough suppressants—hides in plain sight. Its label doesn’t shout warnings or list off a bunch of risks. This can trick us into thinking the medicine works the same way no matter what else we’ve taken that day.
A busy mom fighting a cold grabs cough syrup after work. She’s also on sertraline, an antidepressant. In her mind, these drugs handle separate battles—one keeps sadness away, the other keeps coughs quiet. In truth, mixing these without checking can bring trouble. Dextromethorphan interacts with several common drugs, especially those that tweak serotonin levels, like SSRIs, MAOIs, and some migraine meds. If these combine in your body, serotonin can spike to dangerous levels. The term for this is serotonin syndrome, and the side effects—confusion, twitching, fever—aren’t rare or gentle.
I remember a night in the ER, years ago, where a patient arrived confused and twitchy. He’d taken a regular antidepressant dose, used a popular cough syrup, and didn’t realize his combination could throw his brain chemistry out of balance. It surprised him and his family. The medical team saw the puzzle pieces right away, but his story stuck with me. Many people don’t see the risks lurking in over-the-counter remedies.
Blood thinners enter the conversation here. Dextromethorphan, by itself, rarely causes big issues for the heart or blood. But many cough formulas also pack acetaminophen. This blend can stress the liver, especially in folks using warfarin or similar drugs. Overlapping medications can magnify each other’s side effects, or make the body process them too slowly. Painkillers, sleeping pills, and anti-seizure medications also compete for the same liver enzymes that break down dextromethorphan. The result: higher drug levels in your blood, longer effects, and a greater chance for side effects you never bargained for.
The U.S. Food and Drug Administration warns about this problem, and doctors see cases every year. Pharmacists have tools that track drug interactions. If you walk into any big chain pharmacy, the staff won’t blink twice if you ask whether it’s safe to combine your cough syrup with your daily pills. They pull up a database and share straight answers. Too many folks skip that step, thinking the risk stays low if the medicine comes from a grocery shelf.
Better packaging would help, with bolder warnings about which drugs don't play nice together. More public education around drug combinations matters. Not just pamphlets, but real conversations between patients and healthcare providers. The best habit to pick up: stack new medicines up against your list of current prescriptions. If doubts or questions pop up, call your doctor, nurse, or pharmacy. Medicine works best when it helps, not when it surprises.
Mixing over-the-counter cough suppressants with prescription medicines deserves respect and a little homework. Playing it safe means taking the time to read the label, double-checking with a doctor, and treating every new medicine like an ingredient in a complicated recipe. Each piece on its own offers relief, but toss in the wrong combination, and the outcome can change fast. Knowledge and a quick double-check with a professional make a real difference.
As a parent, the medicine cabinet becomes more familiar than any other shelf in the house. Cold and flu season gets us searching for anything that gives relief when the coughing keeps kids awake at 2 a.m. Dextromethorphan hydrobromide monohydrate, better known as the active ingredient in many over-the-counter cough suppressants, appears on the label of dozens of syrups. Many people grew up with this stuff. The label promises to quiet an irritating cough and offer a better night’s sleep. Yet, a closer look raises some important questions about how safe it really is for children and pregnant women.
Kids process medicines differently than adults. Their bodies and brains are still developing. Health authorities, including the FDA and the American Academy of Pediatrics, have taken a clear stance on this one. They recommend not giving any dextromethorphan-containing remedies to children younger than four years old. There have been serious side effects in kids, including confusion, agitation, breathing problems, and even rare but dangerous incidents like seizures and irregular heartbeats. Sometimes, kids crawl out of bed in the middle of the night, curious about that bottle with the bright sticker; accidental overdose becomes a real risk.
A lot of worried parents have turned to more natural remedies. Chicken soup and honey (for kids over one year) top the list. Doctors often say most coughs go away on their own. It’s not always easy to sit back and wait out a cough, but stacking up side effects against benefit, cough syrups with dextromethorphan often don’t come out looking too good for young kids.
Pregnant women live with a long list of products to avoid. With dextromethorphan, studies in animals haven’t flagged major birth defects, but there aren’t many good studies tracking real-life use in humans. What ends up on the shelves does get into the bloodstream, and pregnant bodies share everything with developing babies. Given the lack of convincing evidence for safety, most obstetricians suggest trying other remedies first—lots of fluids, rest, and maybe a doctor’s check-up just to be safe.
A review published in the journal Obstetrics & Gynecology noted no significant increase in birth defects linked with dextromethorphan use, yet warned the sample size remains too small to give a green light. Being cautious makes sense because new research sometimes changes what we thought we knew. The CDC still encourages pregnant women to talk with their healthcare provider before reaching for over-the-counter products.
Reading labels becomes crucial. So does asking pharmacists what options work for young kids and expectant mothers. Doctors stick with the basics: saline sprays, humidifiers, and honey (again, not for infants). Babysitting a feverish child or being pregnant with a scratchy throat never feels easy; everyone wants effective and safe options. Pharmacies sell many remedies, but old-fashioned patience, fluids, and professional guidance protect the folks most at risk.
Pharmaceutical companies update formulas and add childproof caps, but safety mostly starts at home with paying attention, storing medicine up high, and not mixing medications without advice. Families deserve trustworthy information about what’s going into their bodies. Trust grows by asking questions and challenging assumptions, because health isn’t something anyone should gamble with just for a night of uninterrupted sleep.
| Names | |
| Preferred IUPAC name | (4aS,10S,12bR)-3-methoxy-11-methyl-1,2,3,4,6,6a,7,8,12,12a,12b-undecahydro-10,4a-iminoethanophenanthrene hydrobromide monohydrate |
| Other names |
Dextromethorphan HBr Monohydrate DXM Hydrobromide Monohydrate Dextromethorphan Monohydrate Dextrorphan Hydrobromide Monohydrate |
| Pronunciation | /ˌdɛkstrəˌmɛˈθɔːrfæn haɪˌdrəʊˈbroʊmaɪd ˌmɒnəˈhaɪdreɪt/ |
| Identifiers | |
| CAS Number | 125-69-3 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Dextromethorphan Hydrobromide Monohydrate**: ``` CC1(C2CCC1(CNC3=CC=CC=C3OC2)C)Br.H2O ``` This is the SMILES string, typically used for 3D visualization (including JSmol) of Dextromethorphan Hydrobromide Monohydrate. |
| Beilstein Reference | 1320730 |
| ChEBI | CHEBI:8455 |
| ChEMBL | CHEMBL2105756 |
| ChemSpider | 21544479 |
| DrugBank | DB00514 |
| ECHA InfoCard | 03f0a6a5-8cb8-4ed3-91cd-7c4fcad89957 |
| EC Number | 215-620-7 |
| Gmelin Reference | 79067 |
| KEGG | D00529 |
| MeSH | D003923 |
| PubChem CID | 23665479 |
| RTECS number | QJ6655000 |
| UNII | QNK3S5BNSD |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID8011648 |
| Properties | |
| Chemical formula | C18H25NO•HBr•H2O |
| Molar mass | 370.33 g/mol |
| Appearance | White to off-white crystalline powder |
| Odor | Odorless |
| Density | 0.5 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | 2.8 |
| Acidity (pKa) | 8.3 |
| Basicity (pKb) | 7.84 |
| Magnetic susceptibility (χ) | -76.5 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.536 |
| Dipole moment | 5.6332 D |
| Thermochemistry | |
| Std enthalpy of combustion (ΔcH⦵298) | –4995 kJ/mol |
| Pharmacology | |
| ATC code | R05DA09 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause drowsiness or dizziness. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. If pregnant or breast-feeding, ask a health professional before use. Do not use with any other product containing dextromethorphan. Do not exceed recommended dosage. If symptoms persist, consult a doctor. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Autoignition temperature | 270°C |
| Explosive limits | Non-explosive |
| Lethal dose or concentration | LD50 Rat oral 200 mg/kg |
| LD50 (median dose) | DXM HBr: Mouse oral LD50 = 350 mg/kg |
| NIOSH | HM4000000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 30 mg every 6-8 hours |
| IDLH (Immediate danger) | NIOSH has not established an IDLH value for Dextromethorphan Hydrobromide Monohydrate. |
| Related compounds | |
| Related compounds |
Levomethorphan Dextrorphan Racemethorphan |
